Literature DB >> 25644176

Roles of the Hippo pathway in lung development and tumorigenesis.

Benjamin Yeung1, Jihang Yu1, Xiaolong Yang1.   

Abstract

Lung cancer is the most commonly diagnosed cancer and accounts for one fifth of all cancer deaths worldwide. Although significant progress has been made toward our understanding of the causes of lung cancer, the 5-year survival is still lower than 15%. Therefore, there is an urgent need for novel lung cancer biomarkers and drug targets. The Hippo signaling pathway is an emerging signaling pathway that regulates various biological processes. Recently, increasing evidence suggests that the Hippo pathway may play important roles in not only lung development but also lung tumorigenesis. In this review article, we will summarize the most recent advances and predict future directions on this new cancer research field.
© 2015 UICC.

Entities:  

Keywords:  Hippo pathway; TAZ; YAP; development; lung cancer; tumorigenesis

Mesh:

Substances:

Year:  2015        PMID: 25644176     DOI: 10.1002/ijc.29457

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Regenerative therapy based on miRNA-302 mimics for enhancing host recovery from pneumonia caused by Streptococcus pneumoniae.

Authors:  Yan Wang; Yong Li; Peggy Zhang; Sandy T Baker; Marla R Wolfson; Jeffrey N Weiser; Ying Tian; Hao Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

2.  Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer.

Authors:  Kanchan Singh; Melissa A Pruski; Kishore Polireddy; Neal C Jones; Qingzheng Chen; Jun Yao; Wasim A Dar; Florencia McAllister; Cynthia Ju; Holger K Eltzschig; Mamoun Younes; Cesar Moran; Harry Karmouty-Quintana; Haoqiang Ying; Jennifer M Bailey
Journal:  Oncogene       Date:  2019-09-30       Impact factor: 9.867

3.  Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.

Authors:  A Noto; C De Vitis; M E Pisanu; G Roscilli; G Ricci; A Catizone; G Sorrentino; G Chianese; O Taglialatela-Scafati; D Trisciuoglio; D Del Bufalo; M Di Martile; A Di Napoli; L Ruco; S Costantini; Z Jakopin; A Budillon; G Melino; G Del Sal; G Ciliberto; R Mancini
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 4.  Genetically encoded fluorescent biosensors illuminate kinase signaling in cancer.

Authors:  Wei Lin; Sohum Mehta; Jin Zhang
Journal:  J Biol Chem       Date:  2019-08-21       Impact factor: 5.157

5.  [Metformin inhibits proliferation and promotes apoptosis of HER-2 positive breast cancer cells possibly through the Hippo-YAP pathway].

Authors:  Y Xu; T Xu; Y Xiong; J Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

Review 6.  The hippo pathway provides novel insights into lung cancer and mesothelioma treatment.

Authors:  Xiao-Lan Liu; Rui Zuo; Wen-Bin Ou
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

7.  Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor.

Authors:  Taha Azad; Kazem Nouri; Helena J Janse van Rensburg; Yawei Hao; Xiaolong Yang
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

Review 8.  The HIPPO pathway in gynecological malignancies.

Authors:  Dongying Wang; Jiaxing He; Junxue Dong; Thomas F Meyer; Tianmin Xu
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

9.  A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.

Authors:  T Azad; H J Janse van Rensburg; E D Lightbody; B Neveu; A Champagne; A Ghaffari; V R Kay; Y Hao; H Shen; B Yeung; B A Croy; K L Guan; F Pouliot; J Zhang; C J B Nicol; X Yang
Journal:  Nat Commun       Date:  2018-03-13       Impact factor: 14.919

10.  TAZ induces lung cancer stem cell properties and tumorigenesis by up-regulating ALDH1A1.

Authors:  Jihang Yu; Adel Alharbi; Hongchao Shan; Yawei Hao; Brooke Snetsinger; Michael J Rauh; Xiaolong Yang
Journal:  Oncotarget       Date:  2017-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.